Clinical Trials

150 enrolled

Diabetes Mellitus, Type 1, Hirsutism, Insulin Resistance, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Phase 2 Completed

23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02647827 2024-10-09

PIAII

Phase 2 Recruiting

303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02523898 2024-04-25

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Phase 2 Terminated

388 enrolled

Infertility, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

Phase 1 Unknown

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02611128 2023-11-02

DENND1A

Suspended

65 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01421810 2023-10-27

CBS001

Phase EARLY_PHASE1 Unknown

80 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04075149 2023-10-27

CBS009

24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT05926115 2023-07-03

PEP-Colombia

Unknown

626 enrolled

Anovulation, Endocrine System Diseases, Hirsutism, Menstruation Disturbances, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT05647356 2022-12-12

REFUEL PCOS

16 enrolled

Metabolic Diseases, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

NCT04006171 2021-11-05

CNP

90 enrolled 21 charts

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04645745 2021-01-14

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

36 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04453306 2020-07-01

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Phase 4 Unknown

80 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02052479 2019-10-07

Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)

Phase NA Terminated

12 enrolled

Hirsutism, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Phase NA Terminated

4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03383484 2017-12-26

Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome

45 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01489319 2017-02-10

ELI-ROAS

Phase 1 Terminated

47 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02651636 2016-01-11

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01475565 2015-12-14

Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome

Terminated

2 enrolled

Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Diabetes, Gestational, Hyperandrogenism, Glucose Intolerance

NCT02106676 2015-11-25

Androgen Metabolism and Reproductive Outcome

400 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Phase 4 Unknown

200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01940666 2013-11-06

Presentations of Hyperandrogenic Phenotypes in Taiwanese Women

649 enrolled

Cardiovascular Diseases, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00988078 2012-06-26

Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome

90 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01355536 2011-05-18

Metabolic and Endocrine Status in Women With Prior Preterm Birth

262 enrolled

Gynecologic

Diabetes Mellitus, Hirsutism, Hypertension, Obstetric Labor, Premature, Ovarian Cysts, Polycystic Ovary Syndrome, Hyperandrogenism, Premature Birth

NCT00665171 2008-04-23

Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome

Unknown

1,500 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Phase 4 Completed

50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00317928 2006-10-11

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors